Toward precision medicine and health: Opportunities and challenges in allergic diseases

Journal of Allergy and Clinical Immunology

Volumn 137, Issue 5, 2016, Pages 1289-1300

  Galli, Stephen Joseph ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allergy; asthma; atopic dermatitis; exposome; gene environment interactions; metabolome; microbiome; personalized medicine; pharmacogenomics; stratified medicine

Indexed keywords

ANTIBODY;

ALLERGIC DISEASE; ARTICLE; BIOMETRY; COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; DRUG THERAPY; FAMILY HISTORY; HUMAN; IMMUNOTHERAPY; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; HYPERSENSITIVITY;

HUMANS; HYPERSENSITIVITY; PRECISION MEDICINE;

EID: 84964895250     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2016.03.006     Document Type: Review

References (88)

1. L. Noon Prophylactic inoculation against hay fever Lancet 177 1911 1572 1573
2. J. Freeman, and L. Noon Further observations on the treatment of hay fever by hypodermic inoculations of pollen vaccine Lancet 178 1911 814 817
3. J. Freeman Vaccination against hay fever: report of results during the first three years Lancet 183 1914 1178 1180
4. R.G. Hamilton Allergic sensitization is a key risk factor for but not synonymous with allergic disease J Allergy Clin Immunol 134 2014 360 361
5. S.A. Bock, H.A. Sampson, F.M. Atkins, R.S. Zeiger, S. Lehrer, M. Sachs, and et al. Double-blind, placebo-controlled food challenge (DBPCFC) as an office procedure: A manual J Allergy Clin Immunol 82 1988 986 997
6. N. Mothes, R. Valenta, and S. Spitzauer Allergy testing: the role of recombinant allergens Clin Chem Lab Med 44 2006 125 132
7. R. Treudler, and J.C. Simon Overview of component resolved diagnostics Curr Allergy Asthma Rep 13 2013 110 117
8. C. Lupinek, E. Wollmann, A. Baar, S. Banerjee, H. Breiteneder, B.M. Broecker, and et al. Advances in allergen-microarray technology for diagnosis and monitoring of allergy: the MeDALL allergen-chip Methods 66 2014 106 119
9. K.S. Tuano, and C.M. Davis Utility of component-resolved diagnostics in food allergy Curr Allergy Asthma Rep 15 2015 32
10. K.F. Chung, S.E. Wenzel, J.L. Brozek, A. Bush, M. Castro, P.J. Sterk, and et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma Eur Respir J 43 2014 343 373
11. S.E. Wenzel, L.B. Schwartz, E.L. Langmack, J.L. Halliday, J.B. Trudeau, R.L. Gibbs, and et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics Am J Respir Crit Care Med 160 1999 1001 1008
12. P.G. Woodruff, B. Modrek, D.F. Choy, G. Jia, A.R. Abbas, A. Ellwanger, and et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma Am J Respir Crit Care Med 180 2009 388 395
13. J. Lotvall, C.A. Akdis, L.B. Bacharier, L. Biermer, T.B. Casale, A. Custovic, and et al. Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome J Allergy Clin Immunol 127 2011 355 360
14. T.B. Kim, A.S. Jang, H.S. Kwon, J.S. Park, Y.S. Chang, S.H. Cho, and et al. Identification of asthma clusters in two independent Korean adult asthma cohorts Eur Respir J 41 2013 1308 1314
15. J.L. Simpson, S. Phipps, K.J. Baines, K.M. Oreo, L. Gunawardhana, and P.G. Gibson Elevated expression of the NLRP3 inflammasome in neutrophilic asthma Eur Respir J 43 2014 1067 1076
16. F.D. Martinez, A.L. Wright, L.M. Taussig, C.J. Holberg, M. Halonen, and W.J. Morgan Asthma and wheezing in the first six years of life. The Group Health Medical Associates N Engl J Med 332 1995 133 138
17. F.D. Martinez Gene-environment interactions in asthma: with apologies to William of Ockham Proc Am Thorac Soc 4 2007 26 31
18. M.R. Sears Predicting asthma outcomes J Allergy Clin Immunol 136 2015 829 836
19. S. Desmond-Helmann, C.L. Sawyers, D.R. Cox, C. Fraser-Liggett, S.J. Galli, D.B. Goldstein, and et al. Toward precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease. Committee on a Framework for Developing a New Taxonomy of Disease Prepublication. National Research Council of the National Academies 2011 The National Academies Press Washington (DC)
20. A. Berry, and W.W. Busse Biomarkers in asthmatic patients: has their time come to direct treatment? J Allergy Clin Immunol 137 2016 1317 1324
21. D.P. Potaczek, H. Garn, S. Unger, and H. Renz Antisense molecules: A new class of drugs J Allergy Clin Immunol 137 2016 1334 1346
22. L.K. Tanno, M.A. Calderon, B.J. Goldberg, C.A. Akdis, N.G. Papadopoulos, and P. Demoly Categorization of allergic disorders in the new World Health Organization international classification of diseases Clin Transl Allergy 4 2014 42
23. M.J. Joyner, and N. Paneth Seven questions for personalized medicine JAMA 314 2015 999 1000
24. J. Cussins Direct-to-consumer genetic tests should come with a health warning Pharm J 2015 Available at: http://www.pharmaceutical-journal.com/opinion/comment/direct-to-consumer-genetic-tests-should-come-with-a-health-warning/200167564.article Accessed February 1, 2016
25. K.L. Hudson, and F.S. Collins Perspective. Bringing the common rule into the 21st century N Engl J Med 373 2015 2293 2296
26. J.R. Khoury Genetics and genomics in practice: the continuum from genetic disease to genetic information in health and disease Genet Med 5 2003 261 268
27. I. Agache, K. Sugita, H. Morita, M. Akdis, and C.A. Akdis The complex Type 2 endotype in allergy and asthma: from laboratory to bedside Curr Allergy Asthma Rep 15 2015 29
28. M. Matsusaka, H. Kabata, K. Fukunaga, Y. Suzuki, K. Masaki, T. Mochimaru, and et al. Phenotype of asthma related with high serum periostin levels Allergol Int 64 2015 175 180
29. K. Izuhara, H. Matsumoto, S. Ohta, J. Ono, K. Arima, and M. Ogawa Recent developments regarding periostin in bronchial asthma Allergol Int 64 suppl 2015 S3 S10
30. J.C. Cardet, and E. Israel Update on reslizumab for eosinophilic asthma Expert Opin Biol Ther 15 2015 1531 1539
31. S. Wenzel, D. Wilbraham, R. Fuller, E.B. Getz, and M. Longphre Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies Lancet 370 2007 1422 1431
32. R.E. Slager, G.A. Hawkins, E.J. Ampleford, A. Bowden, L.E. Stevens, M.T. Morton, and et al. Il-4 receptor alpha polymorphisms are predictors of a pharmacogenetic response to a novel il-4/il-13 antagonist J Allergy Clin Immunol 126 2010 875 878
33. J. Corren, R.F. Lemanske, N.A. Hanania, P.E. Korenblat, M.V. Parsey, J.R. Arron, and et al. Lebrikizumab treatment in adults with asthma N Engl J Med 365 2011 1088 1098
34. S. Wenzel, L. Ford, D. Pearlman, S. Spector, L. Sher, F. Skobieranda, and et al. Dupilumab in persistent asthma with elevated eosinophil levels N Engl J Med 368 2013 2455 2466
35. M. Noonan, P. Korenblat, S. Mosesova, H. Scheerens, J.R. Arron, Y. Zheng, and et al. Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids J Allergy Clin Immunol 132 2013 567 574
36. A.L. Kau, and P.E. Korenblat Anti-interleukin 4 and 13 for asthma treatment in the era of endotypes Curr Opin Allergy Clin Immunol 14 2014 570 575
37. Y. Inoue, K. Izuhara, S. Ohta, J. Ono, and N. Shimojo No increase in the serum periostin level is detected in elementary school-age children with allergic diseases Allergol Int 64 2015 289 290
38. J.R. Konradsen, E. Skantz, B. Nordlund, M. Lidegran, A. James, J. Ono, and et al. Predicting asthma morbidity in children using proposed markers of Th2-type inflammation Pediatr Allergy Immunol 26 2015 772 779
39. P. Haldar, C.E. Brightling, and B. Hargadon Mepolizumab and exacerbations of refractory eosinophilic asthma N Engl J Med 360 2009 973 984
40. P. Nair, M.M. Pizzichini, and M. Kjarsgaard Mepolizumab for prednisone-dependent asthma with sputum eosinophilia N Engl J Med 360 2009 985 993
41. M. Castro, S. Mathur, and F. Hargreave Reslizumab for poorly controlled, eosinophilic asthma: A randomized, placebo-controlled study Am J Respir Crit Care Med 184 2011 1125 1132
42. P. Nair What is an "eosinophilic phenotype" of asthma? J Allergy Clin Immunol 132 2013 81 83
43. M. Castro, S.E. Wenzel, and E.R. Bleecker Benralizumab, an anti-interleukin 5 receptor alpha monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: A phase 2b randomised dose-ranging study Lancet Respir Med 2 2014 879 890
44. D. Vercelli Discovering susceptibility genes for asthma and allergy Nat Rev Immunol 8 2008 169 182
45. I. Sayers, C. Ober, and T.C. Yao The genetics of asthma and allergic disease: A 21st century perspective Immunol Rev 242 2011 10 30
46. M.A. Portelli, and E. Hodge Genetic risk factors for the development of allergic disease identified by genome-wide association Clin Exp Allergy 45 2015 21 31
47. G. Du Toit, G. Roberts, P.H. Sayre, H.T. Bahnson, S. Radulovic, A.F. Santos, and et al. Randomized trial of peanut consumption in infants at risk for peanut allergy N Engl J Med 372 2015 803 813
48. D.M. Fleischer, S. Sicherer, M. Greenhawt, D. Campbell, E. Chan, A. Muraro, and et al. Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants J Allergy Clin Immunol 136 2015 258 261
49. A.T. Stefka, T. Feehley, P. Tripathi, J. Qiu, K. McCoy, S.K. Mazmanian, and et al. Commensal bacteria protect against food allergen sensitization Proc Natl Acad Sci U S A 111 2014 13145 13150
50. R. Berni Canani, N. Sangwan, A.T. Stefka, R. Nocerino, L. Paparo, R. Aitoro, and et al. Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants ISME J 10 2016 742 750
51. D.R. Ownby, C.C. Johnson, and E.L. Peterson Exposure to dogs and cats in the first year of life and risk of allergic sensitization at 6 to 7 years of age JAMA 288 2002 963 972
52. C.J. Lodge, K.J. Allen, A.J. Lowe, D.J. Hill, C.S. Hosking, M.J. Abramson, and et al. Perinatal cat and dog exposure and the risk of asthma and allergy in the urban environment: A systematic review of longitudinal studies Clin Dev Immunol 2012 2012 176484
53. K.E. Fujimura, T. Demoor, M. Rauch, A.A. Farugi, S. Jang, C.C. Johnson, and et al. House dust exposure mediates gut microbiome Lactobacillus enrichment and airway immune defense against allergens and virus infection Proc Natl Acad Sci U S A 111 2014 805 811
54. M.J. Ege, M. Mayer, A.C. Normand, J. Genuneit, W.O. Cookson, C. Braun-Fahrländer, and et al. Exposure to environmental microorganisms and childhood asthma N Engl J Med 364 2011 701 709
55. B. Schaub, and D. Vercelli Environmental protection from allergic diseases: from humans to mice and back Curr Opin Immunol 36 2015 88 93
56. K.S. Kim, S.W. Hong, D. Han, J. Yi, J. Jung, B.G. Yang, and et al. Dietary antigens limit mucosal immunity by inducing regulatory T cells in the small intestine Science 351 2016 858 863
57. Y. Zhang, F. Collier, G. Naselli, R. Saffery, M.L. Tang, K.J. Allen, and et al. Cord blood monocyte-derived inflammatory cytokines suppress IL-2 and induce nonclassic "TH2-type" immunity associated with development of food allergy Sci Transl Med 8 2016 321ra8
58. R. Berni Canani, J.A. Gilbert, and C.R. Nagler The role of the commensal microbiota in the regulation of tolerance to dietary allergens Curr Opin Allergy Clin Immunol 15 2015 243 249
59. B.J. Marsland, and O. Salami Microbiome influences on allergy in mice and humans Curr Opin Immunol 36 2015 94 100
60. I. Cho, and M.J. Blaser The human microbiome: At the interface of health and disease Nat Rev Genet 13 2012 260 270
61. A. Nieto, U. Wahn, A. Bufe, P. Eigenmann, S. Halken, G. Hedlin, and et al. Allergy and asthma prevention 2014 Pediatr Allergy Immunol 25 2014 516 533
62. A.A. Litonjua, and S.T. Weiss Is vitamin D deficiency to blame for the asthma epidemic? J Allergy Clin Immunol 120 2007 1031 1035
63. S.T. Weiss, and A.A. Litonjua Vitamin D, the gut microbiome, and the hygiene hypothesis. How does asthma begin? Am J Respir Crit Care Med 191 2015 492 493
64. B.L. Chawes, K. Bønnelykke, J. Stokholm, N.H. Vissing, E. Bjarnadóttir, A.M. Schoos, and et al. Effect of Vitamin D3 supplementation during pregnancy on risk of persistent wheeze in the offspring: A randomized clinical trial JAMA 315 2016 353 361
65. A.A. Litonjua, V.J. Carey, N. Laranjo, B.J. Harshfield, T.F. McElrath, G.T. O'Connor, and et al. Effect of prenatal supplementation with Vitamin D on asthma or recurrent wheezing in offspring by age 3 years: the VDAART randomized clinical trial JAMA 315 2016 362 370
66. W.W. Busse, R.F. Lemanske Jr., and J.E. Gern Role of viral respiratory infections in asthma and asthma exacerbations Lancet 376 2010 826 834
67. S.L. Hefle, and S.L. Taylor How much food is too much? Threshold doses for allergenic foods Curr Allergy Asthma Rep 2 2002 63 66
68. B.K. Ballmer-Weber, M. Fernandez-Rivas, K. Beyer, M. Defernez, M. Sperrin, A.R. Mackie, and et al. How much is too much? Threshold dose distributions for 5 food allergens J Allergy Clin Immunol 135 2015 964 971
69. S.M. Jones, L. Pons, J.L. Roberts, A.M. Scurlock, T.T. Perry, M. Kulis, and et al. Clinical efficacy and immune regulation with peanut oral immunotherapy J Allergy Clin Immunol 124 2009 292 300
70. P.K. Smith, J.O. Hourihane, and P. Lieberman Risk multipliers for severe food anaphylaxis World Allergy Organ J 8 2015 30
71. S.H. Sicherer, and H.A. Sampson Food allergy: epidemiology, pathogenesis, diagnosis, and treatment J Allergy Clin Immunol 133 2014 291 307
72. L. Wang, H.L. McLeod, and R.M. Weinshilboum Genomics and drug response N Engl J Med 364 2011 1144 1153
73. D.A. Meyers, E.R. Bleecker, J.W. Holloway, and S.T. Holgate Asthma genetics and personalised medicine Lancet Respir Med 2 2014 405 415
74. M. Larché, C.A. Akdis, and R. Valenta Immunological mechanisms of allergen-specific immunotherapy Nat Rev Immunol 6 2006 761 771
75. A.J. Frew Allergen immunotherapy J Allergy Clin Immunol 125 suppl 2010 S306 S313
76. C.A. Akdis, and M. Akdis Advances in allergen immunotherapy: Aiming for complete tolerance to allergens Sci Transl Med 7 2015 280ps6
77. M. Jutel, and C.A. Akdis Novel immunotherapy vaccine development Curr Opin Allergy Clin Immunol 14 2014 557 563
78. A.W. Burks, S.M. Jones, R.A. Wood, D.M. Fleischer, S.H. Sicherer, R.W. Lindblad, and et al. Oral immunotherapy for treatment of egg allergy in children N Engl J Med 367 2012 233 243
79. A. Syed, M.A. Garcia, S.-C. Lyu, R. Bucayu, A. Kohli, S. Ishida, and et al. Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3) J Allergy Clin Immunol 133 2014 500 510
80. B.P. Vickery, A.M. Scurlock, M. Kulis, P.H. Steele, J. Kamilaris, J.P. Berglund, and et al. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy J Allergy Clin Immunol 133 2014 468 475
81. R.S. Chinthrajah, J.D. Hernandez, S.D. Boyd, S.J. Galli, and K.C. Nadeau Molecular and cellular mechanisms of food allergy and food tolerance J Allergy Clin Immunol 137 2016 984 997
82. J.F. Ryan, R. Hovde, J. Glanville, S.-C. Lyu, X. Ji, S. Gupta, and et al. Successful immunotherapy induces previously unidentified allergen-specific CD4+ T-cell subsets Proc Natl Acad Sci U S A 113 2016 E1286 E1295
83. A.F. Santos, A. Douiri, N. Bécares, S.Y. Wu, A. Stephens, S. Radulovic, and et al. Basophil activation test discriminates between allergy and tolerance in peanut-sensitized children J Allergy Clin Immunol 134 2014 645 652
84. T. Ferkol, and P. Quinton Precision medicine: At what price? Am J Respir Crit Care Med 192 2015 658 659
85. E.L. Simpson, J.R. Chalmers, J.M. Hanifin, K.S. Thomas, M.J. Cork, W.H. McLean, and et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention J Allergy Clin Immunol 134 2014 818 823
86. L. Hood Systems biology and P4 medicine: Past, present, and future Rambam Maimonides Med J 4 2013 e0012
87. L. Hood, and C. Auffray Participatory medicine: A driving force for revolutionizing healthcare Genome Med 5 2013 110 114
88. T.A.E. Platts-Mills The allergy epidemics: 1870-2010 J Allergy Clin Immunol 136 2015 3 13